Choi Chris, Ess Gabriella, Tippett Ashley, Salazar Luis, Taylor Elizabeth Grace, Ciric Caroline, Reese Olivia, Cheng Andrew, Gibson Theda, Li Wensheng, Hsiao Hui-Mien, Hellmeister Kieffer, Al-Husein Zayna, Hubler Robin, Begier Elizabeth, Liu Qing, Uppal Sonal, Kalina Warren V, Gessner Bradford, Jodar Luis, Kamidani Satoshi, Kao Carol, Yildirim Inci, Anderson Larry J, Rouphael Nadine, Anderson Evan J, Rostad Christina A
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Department of Medicine, Hope Clinic, Emory University School of Medicine, Atlanta, Georgia, USA.
Open Forum Infect Dis. 2025 Jun 20;12(7):ofaf366. doi: 10.1093/ofid/ofaf366. eCollection 2025 Jul.
In adults, the infectious etiologies of acute respiratory illnesses (ARIs) and of exacerbations of cardiopulmonary diseases requiring hospitalization are incompletely understood.
We conducted a prospective surveillance study of older adults hospitalized with acute respiratory illness (ARI) and adults of any age hospitalized with exacerbations of congestive heart failure (CHF) or chronic obstructive pulmonary disease (COPD) at 2 urban hospitals in Atlanta, Georgia, during the 2018-2019 and 2019-2020 respiratory seasons along with contemporaneous healthy controls. All participants had nasopharyngeal and oropharyngeal swabs collected and tested for common viral and bacterial etiologies using a BioFire multiplexed respiratory panel. A subset of patients had paired serological testing for respiratory syncytial virus (RSV), and standard-of-care microbiologic testing results were included when available. Demographics, clinical characteristics, and outcomes were determined through a combination of participant interview and medical record abstraction for hospitalized participants.
A total of 1558 participants were enrolled and included in the analysis. Overall, 757 participants (48.6%) were hospitalized for ARI, 490 (31.5%) for CHF exacerbation, and 311 (20.0%) for COPD exacerbation. At least 1 pathogen was detected in 476 (30.6%) participants, most commonly rhinovirus/enterovirus (127/1558 [8.2%]), influenza (119/1558 [7.6%]), and RSV (92/1558 [5.9%]). Although bacterial and fungal infections were uncommon, these were associated with severe clinical outcomes, including duration of hospitalization and mechanical ventilation.
Respiratory viruses contributed substantially to hospitalization for ARI and cardiopulmonary exacerbations among our cohort of high-risk adults, underscoring the need for effective therapeutic and preventive interventions in this vulnerable population.
在成年人中,急性呼吸道疾病(ARI)以及需要住院治疗的心肺疾病急性加重的感染病因尚未完全明确。
我们在佐治亚州亚特兰大市的两家城市医院,对2018 - 2019年和2019 - 2020年呼吸道疾病流行季因急性呼吸道疾病(ARI)住院的老年人以及因充血性心力衰竭(CHF)或慢性阻塞性肺疾病(COPD)急性加重住院的任何年龄的成年人进行了一项前瞻性监测研究,并设立了同期健康对照。所有参与者均采集了鼻咽拭子和口咽拭子,使用BioFire多重呼吸道检测板检测常见病毒和细菌病因。一部分患者进行了呼吸道合胞病毒(RSV)的配对血清学检测,并在可获得时纳入标准护理微生物检测结果。通过对住院参与者进行参与者访谈和病历摘要相结合的方式确定人口统计学、临床特征和结局。
共纳入1558名参与者并进行分析。总体而言,757名参与者(48.6%)因ARI住院,490名(31.5%)因CHF急性加重住院,311名(20.0%)因COPD急性加重住院。476名(30.6%)参与者检测到至少1种病原体,最常见的是鼻病毒/肠道病毒(127/1558 [8.2%])、流感病毒(119/1558 [7.6%])和RSV(92/1558 [5.9%])。虽然细菌和真菌感染并不常见,但这些与严重的临床结局相关,包括住院时间和机械通气。
呼吸道病毒在我们这组高危成年人中导致ARI和心肺急性加重住院的情况中占很大比例,凸显了在这一脆弱人群中采取有效治疗和预防干预措施的必要性。